South Korean consortium to make 500 million doses of Sputnik V vaccine

South Korean consortium to make 500 million doses of Sputnik V vaccine
By
(0)
South Korean biomedical firms and the Russian Direct Investment Fund are in discussions for the production of Sputnik V vaccines in Korea for export. File Photo by RDIF/EPA-EFE
Feb. 25 (UPI) -- A consortium of South Korean biomedical companies is to manufacture Russia's Sputnik V vaccine.
Industry sources in Korea said the consortium that includes firms Binex, ISU Abxis, Boryung Biopharma, Chong Kun Dang Bio, Quratis, Humendix and Andong Animal Cell Validation Support Center are in negotiations with the Russian Direct Investment Fund over specific production quantities and prices, South Korean news service EDaily reported Thursday.

Related Keywords

Dandong ,Kyonggi Do ,South Korea ,Hungary ,Iran ,Argentina ,Algeria ,United Arab Emirates ,Russia ,Russian ,South Korean ,Boryung Biopharma ,Chong Kun Dang Bio ,Hankook Korus Pharm ,Andong Animal Cell Validation Support Center ,Russian Direct Investment Fund ,தெற்கு கொரியா ,பசி ,இரண் ,அர்ஜெண்டினா ,அல்ஜீரியா ,ஒன்றுபட்டது அரபு அமீரகங்கள் ,ரஷ்யா ,ரஷ்ய ,தெற்கு கொரியன் ,சோங் குன் டங் உயிர் ,ரஷ்ய நேரடி முதலீடு நிதி ,